title: Intranasal Ketamine and Cognitive-Behavioral Therapy for Treatment-Refractory Obsessive-Compulsive Disorder.
authors.affiliation: Department of Psychiatry, Yale University School of Medicine, New Haven, CT thomas.adamsjr@yale.edu; Department of Psychiatry and Child Study Center, Yale University School of Medicine, New Haven, CT; Department of Psychiatry and Child Study Center and Department of Psychology, Interdepartmental Neuroscience Program, Yale University School of Medicine, New Haven, CT.
authors.forename: Thomas G
authors.initials: TG
authors.lastname: Adams
authors.forename: Michael H
authors.initials: MH
authors.lastname: Bloch
authors.forename: Christopher
authors.initials: C
authors.lastname: Pittenger
mesh_terms: D000281:Administration, Intranasal; D000328:Adult; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000494:pharmacology*; D015928:Cognitive Behavioral Therapy / Q000379:methods*; D003131:Combined Modality Therapy; D003865:Major Depressive Disorder / Q000188:drug therapy / Q000628:therapy*; D006801:Humans; D007649:Ketamine / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy / Q000628:therapy*; D055815:Young Adult
chemical_list: D000928:Antidepressive Agents; D007649:Ketamine